Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide

Detalles Bibliográficos
Autores principales: Tiong, Ing S., Stevenson, William S., Wall, Meaghan, Yap, Yan Zhuang, Seymour, John F., Kenealy, Melita, Blombery, Piers
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660393/
https://www.ncbi.nlm.nih.gov/pubmed/38024610
http://dx.doi.org/10.1002/jha2.767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660393/
https://www.ncbi.nlm.nih.gov/pubmed/38024610
http://dx.doi.org/10.1002/jha2.767

Ejemplares similares